Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pharmabiz
8m
Novo Nordisk announces positive results from phase 3 ESSENCE trial of semaglutide 2.4 mg to treat adults with MASH and liver fibrosis
Bagsværd, Denmark Tuesday, November 5, 2024, 10:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Music legend Jones dies
Deploying rapid response team
How to vote
New info about CO breach
California sues Norwalk
Russian incendiary plot?
Alabama gov. treated
Ohio lieutenant apologizes
Dolphin death investigated
Regulator rejects bid
Sues DOJ over poll monitors
Saints fire head coach
NHTSA ends Ford probe
China disputes EU tariffs
Lawyers seek gag order
Ex-officer guilty of murder
Fed rate cut looms
Equity funds outflowing
Halloween shooter charged
NYT tech workers on strike
Machinists contract vote
Rosacea treatment approved
To hear LA map dispute
Want legal leeway
Caribbean storm alert
WI drinking water funding
China crew returns to Earth
Musk giveaways OK'd
Wins Martinsville race
Related topics
Alzheimer's disease
Ozempic
Wegovy
Hims
MASH
Feedback